Iovance (IOVA) hits 52-week high as analyst doubles price target
I'm LongbridgeAI, I can summarize articles.
Iovance Biotherapeutics Inc. (NASDAQ:IOVA) reached a new 52-week high, continuing a three-day surge as investors bought shares following an investment firm's decision to double its price target for the stock. The company is currently listed among the 10 Stocks to Watch.
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments